Literature DB >> 11964526

Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients.

Katsuhiko Fukada1, Hiroko Tomiyama, Chantapong Wasi, Tomoko Matsuda, Shigeru Kusagawa, Hironori Sato, Shinichi Oka, Yutaka Takebe, Masafumi Takiguchi.   

Abstract

OBJECTIVE: To identify and characterize cytotoxic T-cell (CTL) epitopes for HIV-1 clade E using eight known HLA-A*1101-restricted HIV-1 clade B epitopes.
METHODS: Induction of clade E-specific CTL was examined by stimulating peripheral blood mononuclear cells (PBMC) from clade E-infected Thai individuals with the clade E-specific peptide corresponding to the clade B epitopes. Cross-clade and clade-specific CTL recognition for these epitopes was analysed using CTL clones and bulk CTL specific for these epitopes. To clarify the presentation of these epitopes in HIV-1-infected T cells, CTL recognition for the clade E-specific and cross-clade epitopes was investigated using CD4CXCR4 cells infected with an HIV-1 clade E clone.
RESULTS: Three epitopes, which are identical among clades A-E, were recognized as cross-clade CTL epitopes in both individuals. Clade B and E sequences corresponding to three epitopes were recognized as clade-specific epitopes in clade B-infected and clade E-infected individuals, respectively. In contrast, clade E-specific peptides corresponding to two other clade B epitopes failed to elicit clade E-specific CTL. CTL specific for the three cross-clade and three clade E-specific epitopes effectively lysed target cells infected with HIV-1 clade E virus.
CONCLUSIONS: These six epitopes are found to be processed naturally in HIV-1 clade E-infected cells. We show here that a strategy utilizing HIV-1 clade B epitopes is very useful for identifying clade E CTL epitopes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964526     DOI: 10.1097/00002030-200203290-00005

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  10 in total

1.  Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses.

Authors:  Hirokazu Koizumi; Masao Hashimoto; Mamoru Fujiwara; Hayato Murakoshi; Takayuki Chikata; Mohamed Ali Borghan; Atsuko Hachiya; Yuka Kawashima; Hiroshi Takata; Takamasa Ueno; Shinichi Oka; Masafumi Takiguchi
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

2.  Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells.

Authors:  Michael S Bennett; Hwee L Ng; Mirabelle Dagarag; Ayub Ali; Otto O Yang
Journal:  J Virol       Date:  2007-02-28       Impact factor: 5.103

3.  Genome-scale analysis of evolutionary rate and selection in a fast-expanding Spanish cluster of HIV-1 subtype F1.

Authors:  Juan Á Patiño-Galindo; Francisco Domínguez; María T Cuevas; Elena Delgado; Mónica Sánchez; Lucía Pérez-Álvarez; Michael M Thomson; Rafael Sanjuán; Fernando González-Candelas; José M Cuevas
Journal:  Infect Genet Evol       Date:  2018-09-13       Impact factor: 3.342

4.  CD8+ T-cell-mediated cross-clade protection in the genital tract following intranasal immunization with inactivated human immunodeficiency virus antigen plus CpG oligodeoxynucleotides.

Authors:  Janina Q Jiang; Amy Patrick; Ronald B Moss; Kenneth L Rosenthal
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.

Authors:  Ouzama Nicholson; Fay DiCandilo; James Kublin; Xiao Sun; Erin Quirk; Michelle Miller; Glenda Gray; Jean Pape; Michael N Robertson; Devan V Mehrotra; Steven Self; Katherine Turner; Jorge Sanchez; Punnee Pitisuttithum; Ann Duerr; Sheri Dubey; Lisa Kierstead; Danilo Casimiro; Scott M Hammer For The Merck V/Hiv Vaccine Trials Network Study Team
Journal:  AIDS Res Hum Retroviruses       Date:  2010-11-23       Impact factor: 2.205

6.  A novel immunodominant CD8+ T cell response restricted by a common HLA-C allele targets a conserved region of Gag HIV-1 clade CRF01_AE infected Thais.

Authors:  Supranee Buranapraditkun; Ursula Hempel; Patrawadee Pitakpolrat; Rachel L Allgaier; Pattarawat Thantivorasit; Sven-Iver Lorenzen; Sunee Sirivichayakul; William H Hildebrand; Marcus Altfeld; Christian Brander; Bruce D Walker; Praphan Phanuphak; Pokrath Hansasuta; Sarah L Rowland-Jones; Todd M Allen; Kiat Ruxrungtham
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

7.  Non-synonymous Substitutions in HIV-1 GAG Are Frequent in Epitopes Outside the Functionally Conserved Regions and Associated With Subtype Differences.

Authors:  Babatunde A Olusola; David O Olaleye; Georgina N Odaibo
Journal:  Front Microbiol       Date:  2021-01-11       Impact factor: 5.640

8.  Control of HIV-1 Replication by CD8+ T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection.

Authors:  Hung The Nguyen; Nozomi Kuse; Yu Zhang; Hayato Murakoshi; Yosuke Maeda; Yoshiko Tamura; Rie Maruyama; Giang Van Tran; Trung Vu Nguyen; Kinh Van Nguyen; Shinichi Oka; Takayuki Chikata; Masafumi Takiguchi
Journal:  J Virol       Date:  2022-09-26       Impact factor: 6.549

9.  Immunogenicity of ALVAC-HIV vCP1521 in infants of HIV-1-infected women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa.

Authors:  Pontiano Kaleebu; Harr Freeya Njai; Lei Wang; Norman Jones; Isaac Ssewanyana; Paul Richardson; Kenneth Kintu; Lynda Emel; Philippa Musoke; Mary Glenn Fowler; San-San Ou; J Brooks Jackson; Laura Guay; Philip Andrew; Lynn Baglyos; Huyen Cao
Journal:  J Acquir Immune Defic Syndr       Date:  2014-03-01       Impact factor: 3.731

10.  The effect of HLA polymorphisms on the recognition of Gag epitopes in HIV-1 CRF01_AE infection.

Authors:  Busarawan Sriwanthana; Masahiko Mori; Mari Tanaka; Sei Nishimura; Toshiyuki Miura; Panita Pathipvanich; Pathom Sawanpanyalert; Koya Ariyoshi
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.